Apollomics Inc. (APLM) director discloses grant of 500 restricted stock units
Rhea-AI Filing Summary
Apollomics Inc. director Yen Hung Hsien reported initial beneficial ownership of 500 restricted stock units linked to Class A Ordinary Shares. The RSUs were granted on July 20, 2026 and will vest on September 15, 2026, each converting into one share, subject to continued employment. The report is connected to the Holding Foreign Insiders Accountable Act.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Yen Hung Hsien
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Units F2, F1 | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 500 shares (Direct)
Footnotes (2)
- F1. On July 20, 2026, the Reporting Person was granted 500 restricted stock units, all of the restricted stock units granted will be vesting on September 15, 2026, subject to the Reporting Person's continued employment.
- F2. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share.
Key Figures
Restricted Stock Units Granted: 500 restricted stock units
Underlying Class A Ordinary Shares: 500 Class A Ordinary Shares
Vesting Date: September 15, 2026
3 metrics
Restricted Stock Units Granted
500 restricted stock units
Granted to director Yen Hung Hsien on July 20, 2026
Underlying Class A Ordinary Shares
500 Class A Ordinary Shares
Each restricted stock unit represents a right to receive one share
Vesting Date
September 15, 2026
All 500 restricted stock units vest on this date, subject to continued employment
Key Terms
Restricted Stock Units, Class A Ordinary Shares, Holding Foreign Insiders Accountable Act
3 terms
Restricted Stock Units financial
"the Reporting Person was granted 500 restricted stock units, all of the restricted"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Holding Foreign Insiders Accountable Act regulatory
"being filed in connection with the enactment of the Holding Foreign Insiders Accountable Act"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider holding did Yen Hung Hsien report at Apollomics (APLM)?
Yen Hung Hsien reported holding 500 restricted stock units at Apollomics, each linked to one Class A Ordinary Share. These RSUs represent a contingent right to receive 500 Class A Ordinary Shares, providing equity-based compensation aligned with the company’s common equity structure.
When do the reported RSUs for Apollomics (APLM) vest?
The 500 restricted stock units granted to Yen Hung Hsien will vest on September 15, 2026. Vesting is conditioned on the reporting person’s continued employment through that date, after which each vested unit entitles the holder to receive one Class A Ordinary Share.
What does each restricted stock unit represent for Apollomics (APLM)?
Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share of Apollomics. Once vested, the units settle in shares, effectively delivering 500 Class A Ordinary Shares in total if all vesting and employment conditions are satisfied.
On what date were the Apollomics (APLM) RSUs granted to Yen Hung Hsien?
The 500 restricted stock units were granted on July 20, 2026 to director Yen Hung Hsien. This grant date establishes the starting point for the vesting schedule that culminates on September 15, 2026, subject to continued employment requirements being met.
Why was this initial beneficial ownership report made for Apollomics (APLM)?
The initial beneficial ownership report was filed in connection with the Holding Foreign Insiders Accountable Act and related rules. It discloses Yen Hung Hsien’s 500 RSU position so that investors can see the director’s equity-based interest in Apollomics.